3-heteroaryl-2-indolinone compounds for the treatment of disease
US5792783A · kind A · utility
254Cited by
23References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1996 |
| Grant date | Aug 11, 1998 |
| Priority date | — |
| Expiry date | Jun 5, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.